Literature DB >> 2995434

Specificity repertoire of lymphocytes from multiple myeloma patients. I. High frequency of B cells specific for idiotypic and F(ab')2-region determinants on immunoglobulin.

L M Pilarski, M Piotrowska-Krezolak, D J Gibney, L Winger, C Winger, M J Mant, B A Ruether.   

Abstract

The specificity repertoire of B lymphocytes from 14 multiple myeloma patients has been studied using the technique of Epstein-Barr virus (EBV) transformation of peripheral blood lymphocytes (PBL) coupled with clonal analysis by limiting dilution. We find that up to 100% of the B cells from myeloma patients undergoing EBV transformation secrete IgM specific for determinants on the F(ab')2 region of autologous and/or heterologous monoclonal immunoglobulin. In normal individuals 0.02-0.73% of the transformed B cells secrete IgM specific for F(ab')2 determinants. Two patients with monoclonal gammopathy of undetermined significance had only a weak reactivity to F(ab')2 fragments. The number of anti-F(ab')2 B cells was up to 145-fold greater in patients than in normal donors. The majority of antibodies from patient clones recognized determinants shared among 3-12 different F(ab')2 fragments, whereas those originating from normal donor B cells saw determinants expressed on only one or two of the panel of test F(ab')2 fragments. There was a preference for autologous M components and a high proportion of antiidiotypic reactivity in five of eight patients so analyzed. We speculate that these findings indicate the existence of an anti-F(ab')2 immunoregulatory network mediating patient immunodeficiency network mediating patient immunodeficiency, thereby creating an abnormality that may enable the progression of multiple myeloma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995434     DOI: 10.1007/bf00929463

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  29 in total

Review 1.  Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation.

Authors:  R G Lynch; J W Rohrer; B Odermatt; H M Gebel; J R Autry; R G Hoover
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Serological specificity of IgG and IgM antiglobulin antibodies in anti-Gm(a) antisera.

Authors:  M Waller; N Curry; A Richard
Journal:  Clin Exp Immunol       Date:  1968-09       Impact factor: 4.330

3.  Conjugation of antibodies with fluorochromes: modifications to the standard methods.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

Review 4.  Genetics, expression, and function of idiotypes.

Authors:  K Rajewsky; T Takemori
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

5.  Changes in lymphocyte surface immunoglobulins in myeloma and the effect of an RNA-containing plasma factor.

Authors:  Y Chen; N Bhoopalam; V Yakulis; P Heller
Journal:  Ann Intern Med       Date:  1975-11       Impact factor: 25.391

6.  Anti-tumor immunity in B-lymphocyte-deprived mice. III. Immunity to primary Moloney sarcoma virus-induced tumors.

Authors:  J Gordon; H T Holden; S Segal; M Feldman
Journal:  Int J Cancer       Date:  1982-03-15       Impact factor: 7.396

7.  Patterns of isotype commitment in human B cells: limiting dilution analysis of Epstein Barr virus-infected cells.

Authors:  L D Stein; C J Ledgley; N H Sigal
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

8.  Frequencies of the separate human B cell subsets activatable to Ig secretion by Epstein-Barr virus and pokeweed mitogen.

Authors:  O Martínez-Maza; S Britton
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

9.  Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation.

Authors:  H Kubagawa; L B Vogler; J D Capra; M E Conrad; A R Lawton; M D Cooper
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

10.  Characteristics of Epstein-Barr virus activation of human B lymphocytes.

Authors:  A G Bird; S Britton; I Ernberg; K Nilsson
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  3 in total

1.  Humoral immune deficiency in multiple myeloma patients due to compromised B-cell function.

Authors:  L M Pilarski; E J Andrews; M J Mant; B A Ruether
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

2.  Selective induction of light chain synthesis in cultures of blood lymphocytes from patients with IgG myelomatosis.

Authors:  L A Walker; G D Johnson; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

3.  Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patients.

Authors:  H M Serra; M J Mant; B A Ruether; J A Ledbetter; L M Pilarski
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.